These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7187842)

  • 1. [Biopharmaceutics and drug formulation].
    Riccieri FM
    Ann Ist Super Sanita; 1982; 18(3):541-6. PubMed ID: 7187842
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug formulation and biologic availability.
    Poole JW
    Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Galenical possibilities and problems in protraction of drug effects (author's transl)].
    Müller F
    Arzneimittelforschung; 1976; 26(1A):115-21. PubMed ID: 7277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable drug encapsulation in micelles and microemulsions.
    Narang AS; Delmarre D; Gao D
    Int J Pharm; 2007 Dec; 345(1-2):9-25. PubMed ID: 17945446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug permeation through synthetic lipoid membranes. 7. A resorption model with a lecithin membrane for testing the biological availability of drugs].
    Falk M; Fürst W; Lauterbach H
    Pharmazie; 1975 Dec; 30(12):775-9. PubMed ID: 3807
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability: some pharmaceutical factors.
    Fowle AS
    Trans Med Soc Lond; 1975; 91():23-32. PubMed ID: 1236035
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial: Bio-availability and clinical efficacy of a drug.
    Ganguli LK
    J Indian Med Assoc; 1973 Jul; 61(2):94-5. PubMed ID: 4759083
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
    Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bio-availability and its clinical implications.
    Richens A
    Trans Med Soc Lond; 1975; 91():18-22. PubMed ID: 800695
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Formulation of tablets and bioavailability: a biologic method of evaluation].
    Lévy-Appert-Collin M; Willemin JC; Lévy J
    Pharm Acta Helv; 1976; 51(11):348-51. PubMed ID: 1019179
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiologically Based Absorption Modeling to Impact Biopharmaceutics and Formulation Strategies in Drug Development-Industry Case Studies.
    Kesisoglou F; Chung J; van Asperen J; Heimbach T
    J Pharm Sci; 2016 Sep; 105(9):2723-2734. PubMed ID: 26886317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardioactive glycosides as a biopharmaceutical problem].
    Frömming KH
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():29-33. PubMed ID: 611966
    [No Abstract]   [Full Text] [Related]  

  • 14. Tetronic micellization, gelation and drug solubilization: Influence of pH and ionic strength.
    Alvarez-Lorenzo C; Gonzalez-Lopez J; Fernandez-Tarrio M; Sandez-Macho I; Concheiro A
    Eur J Pharm Biopharm; 2007 May; 66(2):244-52. PubMed ID: 17123799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
    Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
    J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation optimization of self-emulsifying preparations of puerarin through self-emulsifying performances evaluation in vitro and pharmacokinetic studies in vivo.
    Quan DQ; Xu GX
    Yao Xue Xue Bao; 2007 Aug; 42(8):886-91. PubMed ID: 17944241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core-modified chitosan-based polymeric micelles for controlled release of doxorubicin.
    Ye YQ; Yang FL; Hu FQ; Du YZ; Yuan H; Yu HY
    Int J Pharm; 2008 Mar; 352(1-2):294-301. PubMed ID: 18096336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro/in vivo evaluation of nano-sized crystals for dissolution rate enhancement of ucb-35440-3, a highly dosed poorly water-soluble weak base.
    Hecq J; Deleers M; Fanara D; Vranckx H; Boulanger P; Le Lamer S; Amighi K
    Eur J Pharm Biopharm; 2006 Nov; 64(3):360-8. PubMed ID: 16846725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of manufacturing and storage conditions on the bioavailability of pharmaceuticals].
    Jaminet F
    Bull Mem Acad R Med Belg; 1976; 131(3-4-5):149-59. PubMed ID: 1021199
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical sciences--1975: literature review of pharmaceutics II.
    Goodhart FW; Eichman ML
    J Pharm Sci; 1976 Aug; 65(8):1101-39. PubMed ID: 789855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.